Suchergebnisse

"Understanding the latest trends and technologies and their impact on enterprises, organizations or state administrations is essential to successfully develop a business in the age of Industry 4.0. This book presents a unique selection of topics and offers the reader an understanding of the implications of the newest technologies such as Artificial Intelligence (AI), Internet of Things (IoT), Augmented Reality (AR) and new trends like social media and sustainable competitiveness in business. It presents the impact of the newest trends on businesses, consumers, and the result on the economy. Contributions showcase the technical perspective of new technologies and provides an innovative and enriching perspective on the implementation of AI in e-commerce and the developmental barriers it can create, modern social media usage in enterprises, the newest trends in innovation management, sustainable competitiveness in the business context, the influence and effect of augmented reality, and the privacy problem of Internet of Things to consumers. This book illustrates how to develop innovation cooperation between business, academia and public institutions through the example of biopharmaceutical industry. It will be of value to researchers, academics, professionals, and students in the fields of economics, management, international business"--

In diesem Sonderband wird die Relevanz von Mittelosteuropa für phänomenbasierte internationale Wirtschaftsforschung und Theorieentwicklung erörtert. Auf empirischer Forschung basierende regionale Erkenntnisse offenbaren die Treiber, Auswirkungen und Implikationen der Umstrukturierung von globalen Wertketten, postpandemische Anpassungen im Management von globalen Wertketten und verschiedene Strategien bei Innovations- und Internationalisierungsaktivitäten von mittelosteuropäischen Unternehmen in turbulenten Zeiten. Ausgewählte Fallstudien zeigen Faktoren auf, die hinter Exit-Entscheidungen, einer frühen Internationalisierung von mittelosteuropäischen Start-ups, Innovationspartnerschaften und Allianzen in bestimmten Sektoren stehen. Die Beiträge heben die Neukonfiguration der Wertschöpfungskette und Innovationskooperationen als entscheidende Prozesse für das zukünftige Wachstum und die Entwicklung Mittel- und Osteuropas in einem sich schnell verändernden internationalen Geschäftsumfeld in Europa und weltweit hervor.

PURPOSE: The aim of the article is to present the development of new partnerships and R&D alliances in the time of COVID-19 pandemic. ; DESIGN/METHODOLOGY/APPROACH: The main method applied in this research was the scientific study. Descriptive, comparative, documentation and desk research methods were used. Additionally, the authors used the methods of deductive and inductive forecasting. ; FINDINGS: The authors present new partnerships undertaken by biopharma (biotech and pharma) companies (in and outside the industry) in order to face pandemic and to discover and deliver a new vaccine for SARS-CoV-2 to the market. In addition, the research projects in the European Union focused on the development of diagnostics, treatments, vaccines, epidemiology, preparedness and response to outbreaks, socioeconomics, production and digital technologies as well infrastructures and data resources that make it possible this research will be presented. ; PRACTICAL IMPLICATIONS: It should be taken into consideration that due to the current situation caused by pandemic the cooperation of companies and all entities in the whole biopharmaceutical R&D innovation ecosystem is even more challenging than before COVID19. Biopharma–university alliances can significantly increase the likelihood of creating better medical therapy for patients. ; ORIGINALITY/VALUE: Results of this cooperation enable a number of innovative projects given the significant pressure on innovativeness and challenges caused by the pandemic. ; This paper includes findings from the research project financed by the research grant of the National Science Centre (Poland) awarded based on the decision no. DEC-2015/19/D/HS4/00414 and project awarded funding from a POWER competitive national grant no. POWR.05.04.00-IP.05-00-006/18 by the Polish Ministry of Health. ; peer-reviewed

Legitimacy in foreign markets, a concept rooted in institutional theory, has traditionally been examined for firms originating from advanced economies. However, it becomes more complex for firms from emerging and post-transition economies. Polish firms began establishing foreign subsidiaries after the accession to the EU, primarily in European markets. In this context, Germany was a key destination for Polish foreign direct investment (FDI). However, scholarly literature about foreign subsidiaries established or acquired by Polish firms is limited. This article presents the analysis of the legitimation strategies employed by post-transition country firms in advanced economies, using Polish subsidiaries in Germany as empirical cases. The empirical context is chosen due to its economic significance and the close linkages between Poland and Germany. With a conceptual framework, the authors synthesise legitimation strategies discussed in scholar literature and highlight some unique challenges for post-transition economy's firms. The article presents outcomes from a qualitative study, extending the framework and offering some fresh perspectives in the field of international business legitimacy.